{"organizations": [], "uuid": "12ee50706fcc137992cd606d3195cb51bdf107bc", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-harvard-bioscience-reports-q4-gaap/brief-harvard-bioscience-reports-q4-gaap-earnings-per-share-0-03-idUSASB0C8FU", "country": "US", "domain_rank": 408, "title": "BRIEF-Harvard Bioscience Reports Q4 GAAP Earnings Per Share $0.03", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.98, "site_type": "news", "published": "2018-03-02T05:07:00.000+02:00", "replies_count": 0, "uuid": "12ee50706fcc137992cd606d3195cb51bdf107bc"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-harvard-bioscience-reports-q4-gaap/brief-harvard-bioscience-reports-q4-gaap-earnings-per-share-0-03-idUSASB0C8FU", "ord_in_thread": 0, "title": "BRIEF-Harvard Bioscience Reports Q4 GAAP Earnings Per Share $0.03", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "harvard bioscience inc", "sentiment": "negative"}, {"name": "harvard bioscience", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 1 (Reuters) - Harvard Bioscience Inc:\n* HARVARD BIOSCIENCE REPORTS FOURTH QUARTER AND YEAR-END 2017 RESULTS\n* SEES FY 2018 NON-GAAP EARNINGS PER SHARE ABOUT $0.19 TO $0.23\n* SEES FY 2018 GAAP EARNINGS PER SHARE ABOUT $0.03 TO $0.07\n* Q4 NON-GAAP EARNINGS PER SHARE $0.05\n* SEES FY 2018 REVENUE $118 MILLION TO $123 MILLION * Q4 REVENUE ROSE 4 PERCENT TO $27.5 MILLION * Q4 GAAP EARNINGS PER SHARE $0.03 * ‍HARVARD BIOSCIENCE IS REAFFIRMING ITS FINANCIAL GUIDANCE FOR FULL YEAR 2018​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-02T05:07:00.000+02:00", "crawled": "2018-03-01T23:23:09.051+02:00", "highlightTitle": ""}